Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder

Published:2005-10-31 Issue:05 Volume:9 Page:517
ISSN:1461-1457
Container-title:The International Journal of Neuropsychopharmacology
language:en
Short-container-title:Int. J. Neuropsychopharm.

Author:

Montgomery Stuart A.,Feighner John P.,Sverdlov Lev,Shrivastava Ram K.,Cunningham Lynn A.,Kiev Ari,Hlavka Joseph,Tonelli George

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/9/5/517/2251433/9-5-517.pdf

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of neuropeptides in depression and anxiety;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2022-03

2. Hamilton scale and MADRS are interchangeable in meta-analyses but can disagree at trial level;Journal of Clinical Epidemiology;2020-08

3. Faster, better, stronger: Towards new antidepressant therapeutic strategies;European Journal of Pharmacology;2015-04

4. Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides;Mini Reviews in Medicinal Chemistry;2013-01-01

5. Behavioral effects of neuropeptides in rodent models of depression and anxiety;Peptides;2010-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP